Lucie Heinzerling
A double-blind, randomized, placebo-controlled Phase III study to assess the efficacy of recMAGE-A3 + AS15 ASCI as adjuvant therapy in patients with MAGE-A3 positive resected stage III melanoma; Short Title: GSK 2132231A Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy iin patients with resexted melanoma
Dec 22, 2010A double-blind, randomized, placebo-controlled Phase III study to assess the efficacy of recMAGE-A3 + AS15 ASCI as adjuvant therapy in patients with MAGE-A3 positive resected stage III melanoma; Short Title: GSK 2132231A Antigen-Specific Cancer Immun...
Fundamental Research - Dec 22, 2010 - Dec 31, 2015
Automatically Closed
Project leader: Heinzerling Lucie
clinical study; The tolerance of acid textiles (pH 5.5-6.5) in patients with atopic and/or dry skin - a randomized, double blind, placebo-controlled study conducted by Kantonsspital St. Gallen
Dec 22, 2010clinical study; The tolerance of acid textiles (pH 5.5-6.5) in patients with atopic and/or dry skin - a randomized, double blind, placebo-controlled study conducted by Kantonsspital St. Gallen
Clinical Studies - Dec 22, 2010 - Dec 22, 2010
Completed
Project leader: Heinzerling Lucie
Assessment of a novel lyophilizable virosome formulation as an adjuvant to the induction of effector cells specific for Melan-A/MART-1 melanoma associated antigen
Feb 1, 2010Die Zahl der Melanompatienten nimmt kontinuierlich zu. Wirksame Therapieansätze nach der chirurgischen Entfernung des Tumors fehlen leider. Chemotherapie und Strahlentherapie sind nur bedingt wirksam. Längst wurde erkannt, dass das menschliche Abwehr...
Fundamental Research - Feb 1, 2010 - Jan 31, 2011
Completed
Project leader: Adamina Michel
Members: Heinzerling Lucie, Weder Patrik
A Phase II, randomized, double-blind, placebo
Dec 7, 2009A Phase II, randomized, double-blind, placebo -controlled, multi-centre study of the savety and efficacy of CT 327, Pegylated K-252, formulated as a cream, when administered twice daily for 14 days to subjects with Mild-to-Moderate atopic Dermatit...
Clinical Studies - Dec 7, 2009 - Oct 30, 2010
Completed
Project leader: Heinzerling Lucie
A randomized, double-blind, placebo controlled Phase
Dec 7, 2009A randomized, double-blind, placebo controlled Phase II, multi-centre study of the efficacy and safety of CT 327, a topical cream formulation of Pegylated K252a, when administered twice daily for eight weeks to patients with mild to moderate Ps...
Clinical Studies - Dec 7, 2009 - Nov 25, 2010
Completed
Project leader: Heinzerling Lucie